Sequence analysis of the published ASPP2 promoter region[35], and the entire open reading frame from ASPP2 low- and ASPP2-high-expressing isolated primary AML blasts did not reveal mutations or genomic changes (data not shown). This evidence concerns the gene TP53BP2 and acute myeloid leukemia.